Tag Archives: VRTX
Peregrine Pharmaceuticals (NASDAQ:PPHM) Stock Soars on Successful Clinical Trial of Bavituximab – PPHM, VRTX, PFE, IMMU
Peregrine Pharmaceuticals (NASDAQ:PPHM), based in Tustin, California, stock continued to hike on Monday following successful clinical examination results for Peregrine’s cancer medicine bavituximab.
Peregrine reported on Friday that patients who were treated with bavituximab in a middle stage clinical check …
Vertex Pharmaceutical Revises Cystic-Fibrosis Results – VRTX, BMY, MRK, PFE, THC, BSX, GNOM, AMRN, DNDN
Vertex Pharmaceutical Inc. (NASDAQ:VRTX) revised the provisional outcomes of a new clinical experiment of cystic-fibrosis patients that had surpassed anticipations and increased optimism that the drug therapy experimented could have smash hit sales capabilities.
Vertex shares plunged almost 15% to …
Earnings Watch; Tenet Healthcare (NYSE:THC) Net Off 19% on Greater Costs – HCA, UHS, ARNA, VRTX, GTXI, DNDN, MAKO, BSX
Tenet Healthcare Corp.’s Q1 earnings dropped 19% as greater costs counterbalance a rise in emergency department visits at the company’s hospitals, as well as an rise in surgeries.
Tenet, which operates 50 hospitals, posted a profit of $64 million, or …
Vertex Pharma (NASDAQ:VRTX) Shares Climbed 50% on Green Mountain- VRTX, IDIX, HGSI, VVUS, DNDN, ACHN, GILD
Shares of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) jumped almost 50% in pre-market trading Monday following the drug developer posted it saw larger than anticipated results in a mid-stage study of a potential treatment for the nearly all severe form of cystic …
U.S. Stocks Off Session Low (YHOO, CTSH, AIG, VRTX, HWAY)
U.S. stocks gained momentum late morning as stocks came off session after struggling in early session as elections during the weekend lifted political uncertainty, which might hurt the region’s potential to overcome from the ongoing debt crisis.
The Dow Jones …
Before the bell market buzz (VRTX, PAY, DTV)
In this report: Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), VeriFone Systems (NYSE:PAY) and DirecTV (NASDAQ:DTV).
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is trading over 7.8 percent higher today after its was announced that Jeffrey Leiden will succeed Matthew Emmens as CEO on February 1st …
